All News about Takeda Pharmaceutical Ltd ADR
Preview: Takeda Pharmaceutical's Earnings
October 30, 2024
Via Benzinga
HUTCHMED Announces Japan Approval for FRUZAQLA® (fruquintinib) Received by Takeda
September 24, 2024
Via GlobeNewswire
Via PressReach
Exposures
Product Safety
Via Benzinga
Takeda Announces New Assignments of Directors
June 26, 2024
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.